Alternate-Day Dosing of Caplacizumab for Immune-Mediated Thrombotic Thrombocytopenic Purpura

This article has no abstract
Epistemonikos ID: 9ec7799e913ec7975c836cb8bbfeb5b3e8d519fe
First added on: Feb 13, 2025